Fosun Pharma

Fosun Pharma is part of the Fosun Group, a conglomerate controlled by founder Guo Guangchang and fellow co-founders. The firm is publicly traded on the Hong Kong and Shanghai stock exchanges, so governance is shared with public shareholders.

The firm invests across the pharmaceutical value chain, from R&D in oncology and infectious diseases to manufacturing generics and medical devices. It also pursues strategic M&A and partnerships, as seen with the BioNTech vaccine collaboration.

Fosun Pharma is a publicly listed pharmaceutical company, not a family office. It operates under corporate governance with a board and public reporting, though the Fosun Group retains significant influence as a controlling shareholder.

China is the primary market, but the firm has international operations in Africa, Europe, and the United States. Subsidiaries in Hong Kong, New York, and Mumbai support global distribution.

The Fosun Group operates the Fosun Foundation, a charitable arm focused on health and education. As a publicly traded entity, Fosun Pharma itself does not maintain a dedicated philanthropy structure.